Thermo Fisher’s Groningen facility specializes in cGMP for (pre)clinical and commercial manufacturing, including mammalian cell culture manufacturing, scale up and cGMP manufacturing of recombinant proteins and monoclonal antibodies. The site leverages decades of expertise in manufacturing, and has a strong regulatory and inspection history, since 1994.
Supporting the growth and development in the biotech drug substance market, and to meet clients’ needs, Groningen has recently expanded its cleanroom area by 29%.
Groningen is part of our European network of biologics sites, which includes Lengnau, Switzerland and part of our Global network including Brisbane, Australia, Hangzhou, China and St. Louis, Missouri, USA.
Specialized capabilities
- cGMP manufacturing for early and late clinical and commercial supply, including process validation and PPQ
- Over 6 years (>70 batches produced) commercial manufacturing experience
- Wide range of single-use technologies
- Modular set-up to match process needs
- Experience in Fed Batch, Perfusion, n-1 Perfusion, and XD® processes
- Experience with all commercial cell lines
